QP-34563457

N/A

Report date: 2023/05/30 15:58:04

Base Information

Drug NameQP-34563457

Drug Alias NameQP-34563457

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionAnti-HER2Interleukin-15 receptor subunit alpha stimulants

TargetsReceptor protein-tyrosine kinase erbB-2Interleukin-15

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesQure Biotechnology (Shanghai) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesQure Biotechnology (Shanghai) Co Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A